NO992609D0 - Syndecan forsterkerelement og dets anvendelse til Õ mÕlrette genekspresjon - Google Patents

Syndecan forsterkerelement og dets anvendelse til Õ mÕlrette genekspresjon

Info

Publication number
NO992609D0
NO992609D0 NO992609A NO992609A NO992609D0 NO 992609 D0 NO992609 D0 NO 992609D0 NO 992609 A NO992609 A NO 992609A NO 992609 A NO992609 A NO 992609A NO 992609 D0 NO992609 D0 NO 992609D0
Authority
NO
Norway
Prior art keywords
syndecan
gene expression
targeted gene
amplifier element
amplifier
Prior art date
Application number
NO992609A
Other languages
English (en)
Other versions
NO992609L (no
Inventor
Markku Jalkanen
Panu Jaakkola
Tapani Vihinen
Original Assignee
Biotie Therapies Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25059389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992609(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotie Therapies Ltd Oy filed Critical Biotie Therapies Ltd Oy
Publication of NO992609D0 publication Critical patent/NO992609D0/no
Publication of NO992609L publication Critical patent/NO992609L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO992609A 1996-12-02 1999-05-31 Syndecan forsterkerelement og dets anvendelse til Õ mÕlrette genekspresjon NO992609L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/760,534 US6017727A (en) 1994-03-07 1996-12-02 Syndecan enhancer element and syndecan stimulation of cellular differentiation
PCT/FI1997/000748 WO1998024921A1 (en) 1996-12-02 1997-12-02 Syndecan enhancer element and its use for targeting gene expression

Publications (2)

Publication Number Publication Date
NO992609D0 true NO992609D0 (no) 1999-05-31
NO992609L NO992609L (no) 1999-05-31

Family

ID=25059389

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992609A NO992609L (no) 1996-12-02 1999-05-31 Syndecan forsterkerelement og dets anvendelse til Õ mÕlrette genekspresjon

Country Status (10)

Country Link
US (1) US6017727A (no)
EP (1) EP0941354A1 (no)
JP (1) JP2001505429A (no)
KR (1) KR20000057361A (no)
AU (1) AU731765B2 (no)
CA (1) CA2272851A1 (no)
HU (1) HUP0001152A3 (no)
NO (1) NO992609L (no)
NZ (1) NZ335328A (no)
WO (1) WO1998024921A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492344B1 (en) 1993-12-01 2002-12-10 Biotie Therapies Corp. Syndecan enhancer element and syndecan stimulation of cellular differentiation
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
WO2009105624A2 (en) * 2008-02-21 2009-08-27 Massachusetts Institute Of Technology Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity
EP4093442A4 (en) * 2020-01-22 2024-05-29 Altius Inst For Biomedical Sciences NOVEL ERYTHROD-SPECIFIC ENHANCERS AND THEIR USES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8806893D0 (en) * 1988-03-23 1988-04-27 Unilever Plc Cosmetic composition
WO1990012033A1 (en) * 1989-03-29 1990-10-18 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
JPH04224522A (ja) * 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
US5147854A (en) * 1990-05-22 1992-09-15 Hoffmann-La Roche Inc. Tgf-b compositions and method
EP0569367B1 (en) * 1991-01-15 1998-05-13 Oy Biotie Therapies Detection of syndecan content in biological materials such as tissues and body fluids for indications of malignant transformations of cells
AU2561792A (en) * 1991-09-06 1993-04-05 Children's Medical Center Corporation Cell-type specific heparan sulfate proteoglycans and their uses
DK0671909T3 (da) * 1992-12-01 2001-03-19 Biotie Therapies Corp Syndecanstimulering af cellulær differentiering
US5726058A (en) * 1992-12-01 1998-03-10 Jalkanen; Markku Syndecan stimulation of cellular differentiation

Also Published As

Publication number Publication date
AU731765B2 (en) 2001-04-05
HUP0001152A2 (en) 2000-07-28
NZ335328A (en) 2000-09-29
KR20000057361A (ko) 2000-09-15
EP0941354A1 (en) 1999-09-15
HUP0001152A3 (en) 2001-09-28
CA2272851A1 (en) 1998-06-11
NO992609L (no) 1999-05-31
US6017727A (en) 2000-01-25
AU5222598A (en) 1998-06-29
JP2001505429A (ja) 2001-04-24
WO1998024921A1 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
NO20002849D0 (no) Sammensetninger og metoder for Õ indusere genekspersjon
DE69725703D1 (de) Kombinierten strömungs-druck und -temperature-fühler
NO984276D0 (no) System og fremgangsmÕte til detektering av dyse- og elektrodeslitasje
IS5525A (is) Innúðabúnaður og aðferð
NO990296D0 (no) HPPD-genet og inhibitorer
NO972446D0 (no) Brönnkomplettering-avstandsfluider og fremgangsmåter
DE1055925T1 (de) Biochip-Lesegerät und Elektrophoresesystem
DK0950186T3 (da) Kromatografikolonne og ventil
DE60044857D1 (de) Programaufnahmeanlage und Programaufnahmemedium
DE69840474D1 (de) Temperaturunempfindlicher siliziumoszillator und daraus erzeugte präzesionsspannungsreferenz
NO994486D0 (no) System og fremgangsmÕte for Õ hÕndtere brukertilgang til Internett
DE69816946D1 (de) Druckkompensationvorrichtung und Druckkompensationverfahren
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO983576D0 (no) Brönnbehandlingsfluider og fremgangsmåter
ITRM950533A0 (it) Sistema di costruzione di prodotti di oreficeria e/o gioielleria, progettati in sezioni, settori e porzioni di settori, variamente assemblabili in sequenza.
DK1060327T3 (da) Indstrømningsdetekteringsapparat og anlæg til dets anvendelse
IS6401A (is) Efnafræðilegar aðferðir og milliefni
IS6168A (is) Vökvaflæði- og þrýstistýrikerfi og aðferð
NO20001551L (no) Takkledningselement, system og anvendelse av elementene
DK0947079T3 (da) System og fremgangsmåder til internettelefoni
DE69835831D1 (de) Verstärker und leitsungsvertsärkungsverfahren
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO992609D0 (no) Syndecan forsterkerelement og dets anvendelse til Õ mÕlrette genekspresjon
NO20005919D0 (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
DE69837507D1 (de) Humanes Hedgehog-Protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application